American Epilepsy Society is ranked #11 of 37 disease & disorders organizations in Chicago, IL, with an America's Best Score of 83 out of 100, based on its 2025 Form 990.
American Epilepsy Society is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G540). Contributions are tax-deductible.
141 West Jackson Blvd, Chicago, IL 60604-2992
Among the 46 scored disease & disorders organizations in Chicago, American Epilepsy Society holds 20 months of operating reserves (peer median 15.1 months), runs a typical yearly surplus of 2.3% (peers: surplus of 4.1%), and has grown spending 8.6% a year (peers: grown spending 8.3% a year).
In fiscal year 2025 it reported $11,878,127 in revenue and $11,608,562 in expenses, with contributions making up 22.2% of revenue.
The American Epilepsy Society promotes research and education for professionals dedicated to the prevention, treatment, and cure of epilepsy.
Largest programs · fiscal year 2025
Meeting for medical professionals to enhance knowledge about the latest therapies to treat epilepsy and steps toward finding a cure for epilepsy.$4,808,261 spent · 46.7% of program spending
Continuing medical education for medical professionals, website to educate the public and members, and other programs aimed to furthering epilepsy therapies.$3,368,350 spent · 32.7% of program spending
Research geared towards finding a cure for epilepsy and new, more effective treatments for the disease.$2,119,877 spent · 20.6% of program spending
Where each dollar went · fiscal year 2025
Of every dollar it spent, 89¢ went to programs, 10¢ to management and 1¢ to fundraising.
Programs $10,296,488
Management $1,149,736
Fundraising $162,338
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
89%
Meets
Compared with Chicago peers
Measure
This organization
Peer median
Operating reserves
20.0 mo
15.1 mo
Typical margin
+2.3%
+4.1%
Spending growth
+8.6% / yr
+8.3% / yr
Debt load
12.0%
10.5%
Peers: the 46 Chicago disease & disorders organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$11,878,127Fiscal year 2025
Expenses$11,608,562Fiscal year 2025
Total assets$22,020,378Fiscal year 2025
Total liabilities$2,630,487Fiscal year 2025
Fiscal year ending June2025
Revenue$11,878,127
Expenses$11,608,562
Net income$269,565
Net assets$19,389,891
Notable sources of revenue
Percent of total revenue
Contributions
$2,636,436
22.2%
Program services
$8,130,603
68.5%
Investment income
$884,891
7.4%
Other (net)
$226,197
1.9%
Assets / debt
Total assets
$22,020,378
Total liabilities
$2,630,487
Net assets
$19,389,891
Compensation
Not in our extract for this year.
Fiscal year ending June2023
Revenue$10,000,415
Expenses$9,832,791
Net income$167,624
Net assets$16,893,539
Notable sources of revenue
Percent of total revenue
Contributions
$2,630,159
26.3%
Program services
$6,905,419
69.1%
Investment income
$268,816
2.7%
Other (net)
$196,021
2.0%
Assets / debt
Total assets
$19,332,170
Total liabilities
$2,438,631
Net assets
$16,893,539
Compensation
Not in our extract for this year.
Fiscal year ending June2022
Revenue$9,656,912
Expenses$9,053,944
Net income$602,968
Net assets$15,806,092
Notable sources of revenue
Percent of total revenue
Contributions
$2,708,916
28.1%
Program services
$6,278,230
65.0%
Investment income
$265,827
2.8%
Other (net)
$403,939
4.2%
Assets / debt
Total assets
$17,665,869
Total liabilities
$1,859,777
Net assets
$15,806,092
Compensation
Officers and key employees
$384,383
Share of expenses
4.2%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?